EU ingredient rules · 1 min read
Musk Xylene in cosmetics: EU rules
Quick answer: Musk Xylene is a restricted cosmetic ingredient in the EU: Annex III (entry 96) allows it only within set limits. CosIng lists its functions as fragrance and perfuming.
Key facts
| INCI name | MUSK XYLENE |
|---|---|
| CAS number | 81-15-2 |
| EC number | 201-329-4 |
| EU status | Restricted (Annex III, entry 96) |
| Functions (CosIng) | Fragrance, Perfuming |
What it does in a product
- Fragrance: Adds or covers a scent.
- Perfuming: Used to add scent, and listed in CosIng under a perfuming name.
Annex III: restricted substances, entry 96
Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.
The entry is listed as 5-tert-Butyl-2,4,6-trinitro-m-xylene
Maximum concentration in the ready-to-use product:
(a) 1.0% in fine fragrance (b) 0.4% in eau de toilette (c) 0.03% in other products
Product type or body part:
All cosmetic products, with the exception of oral products
Note: 'Due to environmental concerns, musk xylene is included in the authorisation list (Annex IV) of REACH. Musk xylene cannot be placed on the market or used unless authorisation has been granted under REACH’
Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.
Scientific Committee on Consumer Safety (SCCS) opinions:
Why it matters for shelf life
The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.
Not sure how to read a label? What an INCI name is · How ingredient lists work
Source
European Commission, CosIng (Cosmetic Ingredients database), entries for MUSK XYLENE and Annex III/96, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.